Quercetin: A flavonol with multifaceted therapeutic applications?

Fitoterapia

Volumn 106, Issue , 2015, Pages 256-271

  D'Andrea, Gabriele ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Dietary sources; Drug interactions; Metabolism; Quercetin; Therapeutic applications; Toxicity

Indexed keywords

QUERCETIN; ANTIOXIDANT; GLYCOSIDE;

AGING; ALLERGY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTHRITIS; ASTHMA; CHEMICAL STRUCTURE; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG ABSORPTION; DRUG DEGRADATION; DRUG DISPOSITION; DRUG METABOLISM; DRUG TRANSFORMATION; EXERCISE; HUMAN; IMMUNITY; INFECTION; MOOD DISORDER; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; REVIEW; ANIMAL; BIOAVAILABILITY; CHEMISTRY; DRUG INTERACTION; FRUIT; INTESTINE; KIDNEY; LIVER; METABOLISM; VEGETABLE;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; DRUG INTERACTIONS; FRUIT; GLYCOSIDES; HUMANS; INTESTINES; KIDNEY; LIVER; MOLECULAR STRUCTURE; QUERCETIN; VEGETABLES;

EID: 84942509629     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2015.09.018     Document Type: Review

References (209)

1. M.G. Hertog, P.C. Hollman, M.B. Katan, and D. Kromhout Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands Nutr. Cancer 20 1993 21 29
2. J.V. Formica, and W. Regelson Review of the biology of quercetin and related bioflavonoids Food Chem. Toxicol. 33 1995 1061 1080
3. G.R. Beecher, B.A. Warden, and H. Merken Analysis of tea polyphenols Proc. Soc. Exp. Biol. Med. 220 1999 267 270
4. J. Linseisen, J. Radtke, and G. Wolfram Flavonoidzufuhr erwachsener in einem bayrischen teilkollektiv der nationalen verzehrsstudie Z. Ernahrungswiss. 36 1997 403 412
5. H. Böhm, H. Boeing, J. Hempel, B. Raab, and A. Kroke Flavonols, flavone and anthocyanins as natural antioxidants of food and their possible role in the prevention of chronic diseases Z. Ernahrungswiss. 37 1998 147 163
6. M. Harwood, B. Danielewska-Nikiel, J.F. Borzelleca, G.W. Flamm, G.M. Williams, and T.C. Lines A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties Food Chem. Toxicol. 45 2007 2179 2205
7. W. Bors, C. Michel, and M. Saran Flavonoid antioxidants: rate constants for reactions with oxygen radicals Methods Enzymol. 234 1994 420 429
8. G. Galati, M.Y. Moridani, T.S. Chan, and P.J. O'Brien Peroxidative metabolism of apigenin and naringenin versus luteolin and quercetin: glutathione oxidation and conjugation Free Radic. Biol. Med. 30 2001 370 382
9. H.M. Awad, M.G. Boersma, S. Boeren, P.J. van Bladeren, J. Vervoort, and I.M. Rietjens The regioselectivity of glutathione adduct formation with flavonoid quinone/quinone methides is pH-dependent Chem. Res. Toxicol. 15 2002 343 351
10. R. Vrijsen, Y. Michotte, and A. Boeye Metabolic activation of quercetin mutagenicity Mutat. Res. 232 1990 243 248
11. J. Jurado, E. Alejandre-Duran, A. Alonso-Moraga, and C. Pueyo Study on the mutagenic activity of 13 bioflavonoids with the Salmonella Ara test Mutagenesis 6 1991 289 295
12. J. Rueff, J. Gaspar, and A. Laires Structural requirements for mutagenicity of flavonoids upon nitrosation. A structure-activity study Mutagenesis 10 1995 325 328
13. I.D. Silva, J. Gaspar, G.G. da Costa, A.S. Rodrigues, A. Laires, and J. Rueff Chemical features offlavonols affecting their genotoxicity. Potential implications in their use as therapeutical agents Chem. Biol. Interact. 124 2000 29 51
14. V.C. de Boer, A.A. Dihal, H. van der Woude, I.C. Arts, S. Wolffram, G.M. Alink, I.M. Rietjens, J. Keijer, and P.C. Hollman Tissue distribution of quercetin in rats and pigs J. Nutr. 135 2005 1718 1725
15. X. Chen, O.Q. Yin, Z. Zuo, and M.S. Chow Pharmacokinetics and modeling of quercetin and metabolites Pharm. Res. 22 2005 892 901
16. E.U. Graefe, J. Wittig, S. Mueller, A.K. Riethling, B. Uehleke, B. Drewelow, H. Pforte, G. Jacobasch, H. Derendorf, and M. Veit Pharmacokinetics and bioavailability of quercetin glycosides in humans J. Clin. Pharmacol. 41 2001 492 499
17. K. Kawabata, R. Mukai, and A. Ishisaka Quercetin and related polyphenols: new insights and implications for their bioactivity and bioavailability Food Funct. 6 2015 1399 1417
18. C. Fischer, V. Speth, S. Fleig-Eberenz, and G. Neuhaus Induction of zygotic polyembryos in wheat: influence of auxin polar transport Plant Cell 9 1997 1767 1780
19. M. Shiro Research for vitamin P J. Biochem. 29 1938 487 501
20. R.F. de Souza, and W.F. De Giovani Antioxidant properties of complexes of flavonoids with metal ions Redox Rep. 9 2004 97 104
21. C.G. Heijnen, G.R.M.M. Haenen, R.M. Oostveen, E.M. Stalpers, and A. Bast Protection of flavonoids against lipid peroxidation: the structure activity relationship revisited Free Radic. Res. 36 2002 575 581
22. Y. Hanasaki, S. Ogawa, and S. Fukui The correlation between active oxygens scavenging and antioxidative effects of flavonoids Free Radic. Biol. Med. 16 1994 845 850
23. T.P. Cushnie, and A.J. Lamb Antimicrobial activity of flavonoids Int. J. Antimicrob. Agents 26 2005 343 356
24. S.A. van Acker, M.N. Tromp, G.R.M.M. Haenen, W.J. van der Vijgh, and A. Bast Flavonoids as scavengers of nitric oxide radical Biochem. Biophys. Res. Commun. 214 1995 755 759
25. G.R.M.M. Haenen, and A. Bast Nitric oxide radical scavenging of flavonoids Methods Enzymol. 301 1999 490 503
26. G.R.M.M. Haenen, J.B. Paquay, R.E. Korthouwer, and A. Bast Peroxynitrite scavenging byflavonoids Biochem. Biophys. Res. Commun. 236 1997 591 593
27. C.G. Heijnen, G.R.M.M. Haenen, F.A. van Acker, W.J. van der Vijgh, and A. Bast Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups Toxicol. in Vitro 15 2001 3 6
28. P.C.H. Hollman, and M.B. Katan Absorption, metabolism and health effects of dietary flavonoids in man Biomed. Pharmacother. 51 1997 305 310
29. 2 +: a model experiment Life Sci. 83 2008 164 169
30. R. Kahl, and A.G. Hildebrandt Methodology for studying antioxidant activity and mechanisms of action of antioxidants Food Chem. Toxicol. 24 1986 1007 1014
31. L. Balazs, and M. Leon Evidence of an oxidative challenge in the Alzheimer's brain Neurochem. Res. 19 1994 1131 1137
32. M.A. Ansari, M.A. Hafiz, G. Joshi, W.O. Opii, and D.A. Butterfield Protective effect of quercetin in primary neurons against Aβ (1-42): relevance to Alzheimer's disease J. Nutr. Biochem. 20 2009 269 275
33. D.A. Shoskes, S.I. Zeitlin, A. Shahed, and J. Rajfer Quercetin in men with category III chronic prostatitis: a preliminary prospective, double blinded, placebo controlled trial Urology 54 1999 960 963
34. A.N. Begum, and J. Terao Protective effect of quercetin against cigarette tar extract induced impairment of erythrocyte deformability J. Nutr. Biochem. 13 2002 265 272
35. S.R. McAnulty, L.S. McAnulty, D.C. Nieman, J.C. Quindry, P.A. Hosick, M.H. Hudson, L. Still, D.A. Henson, G.L. Milne, J.D. Morrow, C.L. Dumke, A.C. Utter, and N.T. Triplett Chronic quercetin ingestion and exercise-induced oxidative damage and inflammation Appl. Physiol. Nutr. Metab. 33 2008 254 262
36. M.J.T.J. Arts, J.S. Dallinga, H.P. Voss, G.R.M.M. Haenen, and A. Bast A new approach to assess the total antioxidant capacity using the TEAC assay Food Chem. 88 2004 567 570
37. S.M. Nabavi, S.F. Nabavi, S. Eslami, and A.H. Moghaddam In vivo protective effects of quercetin against sodium fluoride-induced oxidative stress in the hepatic tissue Food Chem. 132 2012 931 935
38. S.M. Nabavi, S.F. Nabavi, S. Habtemariam, A.H. Moghaddam, and A.M. Latifi Ameliorative effects of quercetin on sodium fluoride-induced oxidative stress in rat's kidney Ren. Fail. 34, 2012 901 906
39. S.F. Nabavi, S.M. Nabavi, M. Mirzaei, and A.H. Moghaddam Protective effect of quercetin against sodium fluoride induced oxidative stress in rat's heart Food Funct. 3 2012 437 441
40. A.W. Boots, H. Li, R.P.F. Schins, R. Duffin, J.W.M. Heemskerk, A. Bast, and G.R.M.M. Haenen The quercetin paradox FEBS Lett. 222 2007 89 96
41. B.N. Ames, F.D. Lee, and W.E. Durston An improved bacterial test system for the detection and classification of mutagens and carcinogens Proc. Natl. Acad. Sci. U. S. A. 70 1973 782 786
42. T. Okamoto Safety of quercetin for clinical application (review) Int. J. Mol. Med. 16 2005 275 278
43. D. Utesch, K. Feige, J. Dasenbrock, T.H. Broschard, M. Harwood, B. Danielewska-Nikiel, and T.C. Lines Evaluation of the potential in vivo genotoxicity of quercetin Mutat. Res. 654 2008 38 44
44. A. Bast, and G.R.M.M. Haenen The toxicity of antioxidants and their metabolites Environ. Toxicol. Pharmacol. 11 2002 251 258
45. P.C. Hollman, and M.B. Katan Dietary flavonoids: intake, health effects and bioavailability Food Chem. Toxicol. 37 1999 937 942
46. C.F. Skibola, and M.T. Smith Potential health impacts of excessive flavonoid intake Free Radic. Biol. Med. 29 2000 375 383
47. A.W. Boots, G.R.M.M. Haenen, G.J. den Hartog, and A. Bast Oxidative damage shifts from lipid peroxidation to thiol arylation by catechol-containing antioxidants Biochim. Biophys. Acta 1583 2002 279 284
48. A.W. Boots, N. Kubben, G.R.M.M. Haenen, and A. Bast Oxidized quercetin reacts with thiols rather than with ascorbate: implication for quercetin supplementation Biochem. Biophys. Res. Commun. 308 2003 560 565
49. E.E. Mendoza, and R. Burd Quercetin as a systemic chemopreventative agent: structural and functional mechanisms Mini-Rev. Med. Chem. 11 2011 1216 1221
50. J.T. Brown A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds Mutat. Res. 75 1980 243 277
51. A.E. Mitchell, Y.J. Hong, E. Koh, D.M. Barrett, D.E. Bryant, R.F. Denison, and S. Kaffka Ten-year comparison of the influence of organic and conventional crop management practices on the content of flavonoids in tomatoes J. Agric. Food Chem. 55 2007 6154 6159
52. Day, A.J.; Williamson, G. Human metabolism of dietary quercetin glycosides. In: Plant Polyphenols 2: Chemistry, Biology, Pharmacology, Ecology. Basic Life Sciences, Gross, G.G.; Hemingway, R.W.; Yoshida, T. (Eds.); Kluwer Academic/Plenum Publishers: New York, 1999; 66, pp. 415-434.
53. J.M. Harnly, R.F. Doherty, G.R. Beecher, J.M. Holden, D.B. Haytowitz, S. Bhagwat, and S. Gebhardt Flavonoid content of US fruits, vegetables, and nuts J. Agric. Food Chem. 54 2006 9966 9977
54. M.G.L. Hertog, P.C.H. Hollman, and B. van de Putte Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices J. Agric. Food Chem. 41 1993 1242 1246
55. L. Sampson, E. Rimm, P.C. Hollman, J.H. de Vries, and M.B. Katan Flavonol and flavone intakes in US health professionals J. Am. Diet. Assoc. 102 2002 1414 1420
56. N. Fang, S. Yu, and T.J. Mabry Flavonoids from Ageratina calophylla Phytochemistry 25 1986 2684 2686
57. L.-M. Zeng, C.-J. Wang, J.-Y. Su, D. Li, N.L. Owen, and Y. Lu Flavonoids from the red alga Acanthophora spicifera Chin. J. Chem. 19 2010 1097 1100
58. S. Del Santo, and F. Guzzo The plasticity of the grapevine berry transcriptome MetaboLights 39 2013
59. J. Kühnau The flavonoids: a class of semi-essential food components: their role in human nutrition World Rev. Nutr. Diet. 24 1976 117 191
60. E. Jones, and R.E. Hughes Quercetin, flavonoids and the life-span of mice Exp. Gerontol. 17 1982 213 221
61. E.C. Rimm, M.B. Katan, A. Ascherio, M.J. Stampfer, and W.C. Willett Relation between intake of flavonoids and risk for coronary heart disease in male health professionals Ann. Intern. Med. 125 1996 384 389
62. M.G.L. Hertog, D. Kromhout, C. Aravanis, H. Blackburn, R. Buzina, F. Fidanza, S. Giampaoli, A. Jansen, A. Menotti, S. Nedeljkovic, M. Pekkarinen, B.S. Simic, H. Toshima, E.J.M. Feskens, P.C.H. Hollman, and M.B. Katan Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study Arch. Intern. Med. 155 1995 381 386
63. P. Knekt, R. Järvinen, R. Seppänen, M. Heliövaara, L. Teppo, E. Pukkala, and A. Aromaa Dietary intake of flavonoids and the risk of lung cancer and other malignant neoplasms Am. J. Epidemiol. 146 1997 223 230
64. M. Kimira, Y. Arai, K. Shimoi, and S. Watanabe Japanese intake of flavonoids and isoflavonoids from foods J. Epidemiol. 8 1998 168 175
65. L. Johannot, and S.M. Somerset Age-related variations in flavonoid intake and sources in the Australian population Public Health Nutr. 9 2006 1045 1054
66. J. Lin, S.M. Zhang, K. Wu, W.C. Willett, C.S. Fuchs, and E. Giovannucci Flavonoid intake and colorectal cancer risk in men and women Am. J. Epidemiol. 164 2006 644 651
67. M.J. Jackson The assessment of bioavailability of micronutrients: introduction Eur. J. Clin. Nutr. 51 1997 S1 S2
68. P.L. Toutain, and A. Bousquet-Melou Bioavailability and its assessment J. Vet. Pharmacol. Ther. 27 2004 455 466
69. S. Scholz, and G. Williamson Interactions affecting the bioavailability of dietary polyphenols in vivo Int. J. Vitam. Nutr. Res. 77 2007 224 235
70. R. Gugler, M. Leschik, and H.J. Dengler Disposition of quercetin in man after single oral and intravenous doses Eur. J. Clin. Pharmacol. 9 1975 229 234
71. T. Walle, U.K. Walle, and P.V. Halushka Carbon dioxide is the major metabolite of quercetin in humans J. Nutr. 131 2001 2648 2652
72. Y. Zhang, Y. Li, C. Cao, J. Cao, W. Chen, Y. Zhang, C. Wang, J. Wang, X. Zhang, and X. Zhao Dietary flavonol and flavones intakes and their major food sources in Chinese adults Nutr. Cancer 62 2010 1120 1127
73. A.W. Boots, G.R. Haenen, and A. Bast Health effects of quercetin: from antioxidant to nutraceutical Eur. J. Pharmacol. 585 2008 325 337
74. C. Manach, G. Williamson, C. Morand, A. Scalbert, and C. Remesy Bioavailability and bioefficacy of polyphenols in humans. Review of 97 bioavailability studies Am. J. Clin. Nutr. 81 2005 230S 242S
75. G. Tamura, C. Gold, A. Ferro-Luzzi, and B.N. Ames Fecalase: a model for activation of dietary glycosides to mutagens by intestinal flora Proc. Natl. Acad. Sci. U. S. A. 77 1980 4961 4965
76. C. Manach, C. Morand, V. Crespy, C. Demigné, O. Texier, F. Régérat, and C. Rémésy Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties FEBS Lett. 426 1998 331 336
77. J.H. Moon, R. Nakata, S. Oshima, T. Inakuma, and J. Terao Accumulation of quercetin conjugates in blood plasma after the short-term ingestion of onion by women Am. J. Physiol. Regul. Integr. Comp. Physiol. 279 2000 R461 R467
78. J. Moon, T. Tsushida, K. Nakahara, and J. Terao Identification of quercetin 3-O-β-d-glucuronide an antioxidative metabolite in rat plasma after oral administration of quercetin Free Radic. Biol. Med. 30 2001 1274 1285
79. C. Manach, O. Texier, F. Régérat, G. Agullo, C. Demigné, and C. Rémésy Dietary quercetin is recovered in rat plasma as conjugated derivatives of isorhamnetin and quercetin Nutr. Biochem. 7 1996 375 380
80. E.L. da Silva, M.K. Piskula, N. Yamamoto, J.H. Moon, and J. Terao Quercetin metabolites inhibit copper ion-induced lipid peroxidation in rat plasma FEBS Lett. 430 1998 405 408
81. Y. Guo, and R.S. Bruno Endogenous and exogenous mediators of quercetin bioavailability J. Nutr. Biochem. 26 2015 201 210
82. P.C. Hollman, M. van der Gaag, M.J. Mengelers, J.M. van Trijp, J.H. de Vries, and M.B. Katan Absorption and disposition kinetics of the dietary antioxidant quercetin in man Free Radic. Biol. Med. 21 1996 703 707
83. J.A. Conquer, G. Maiani, E. Azzini, A. Raguzzini, and B.J. Holub Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects J. Nutr. 128 1998 593 597
84. S.C. Bischoff Quercetin: potentials in the prevention and therapy of disease Curr. Opin. Clin. Nutr. Metab. Care 11 2008 733 740
85. V. Crespy, C. Morand, C. Besson, C. Manach, C. Demigne, and C. Remesy Quercetin, but not its glycosides, is absorbed from the rat stomach J. Agric. Food Chem. 50 2002 618 621
86. V. Crespy, C. Morand, C. Manach, C. Besson, C. Demigne, and C. Remesy Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen Am. J. Physiol. 277 1999 120 126
87. M. Nait Chabane, A. Al Ahmad, J. Peluso, C.D. Muller, and G. Ubeaud Quercetin and naringenin transport across human intestinal Caco-2 cells J. Pharm. Pharmacol. 61 2009 1473 1483
88. I.C. Arts, A.L. Sesink, M. Faassen-Peters, and P.C. Hollman The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides Br. J. Nutr. 91 2004 841 847
89. K. Nemeth, G.W. Plumb, J.G. Berrin, N. Juge, R. Jacob, H.Y. Naim, G. Williamson, D.M. Swallow, and P.A. Kroon Deglycosylation by small intestinal epithelial cell β-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans Eur. J. Nutr. 42 2003 29 42
90. A.J. Day, J.M. Gee, M.S. DuPont, I.T. Johnson, and G. Williamson Absorption of quercetin-3-glucoside and quercetin-4′-glucoside in the rat small intestine: the role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter Biochem. Pharmacol. 65 2003 1199 1206
91. I.B. Jaganath, W. Mullen, C.A. Edwards, and A. Crozier The relative contribution of the small and large intestine to the absorption and metabolism of rutin in man Free Radic. Res. 40 2006 1035 1046
92. D.H. Kim, E.A. Jung, I.S. Sohng, J.A. Han, T.H. Kim, and M.J. Han Intestinal bacterial metabolism of flavonoids and its relation to some biological activities Arch. Pharm. Res. 21 1998 17 23
93. A.M. Aura, K.A. O'Leary, G. Williamson, M. Ojala, M. Bailey, R. Puupponen-Pimiä, A.M. Nuutila, K.M. Oksman-Caldentey, and K. Poutanen Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro J. Agric. Food Chem. 50 2002 1725 1730
94. D. Del Rio, A. Rodriguez-Mateos, J.P. Spencer, M. Tognolini, G. Borges, and A. Crozier Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases Antioxid. Redox Signal. 18 2013 1818 1892
95. C.J. Omiecinski, J.P. Vanden Heuvel, G.H. Perdew, and J.M. Peters Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities Toxicol. Sci. 120 2011 49 75
96. A. Gradolatto, M.C. Canivenc-Lavier, J.P. Basly, M.H. Siess, and C. Teyssier Metabolism of apigenin by rat liver phase I and phase ii enzymes and by isolated perfused rat liver Drug Metab. Dispos. 32 2004 58 65
97. H. van der Woude, M.G. Boersma, J. Vervoort, and I.M. Rietjens Identification of 14 quercetin phase II mono- and mixed conjugates and their formation by rat and human phase II in vitro model systems Chem. Res. Toxicol. 17 2004 1520 1530
98. B.A. Graf, C. Ameho, G.G. Dolnikowski, P.E. Milbury, C.Y. Chen, and J.B. Blumberg Rat gastrointestinal tissues metabolize quercetin J. Nutr. 136 2006 39 44
99. K. Murota, R. Cermak, J. Terao, and S. Wolffram Influence of fatty acid patterns on the intestinal absorption pathway of quercetin in thoracic lymph duct-cannulated rats Br. J. Nutr. 109 2013 2147 2153
100. A.L. Sesink, I.C. Arts, V.C. de Boer, P. Breedveld, J.H. Schellens, P.C. Hollman, and F.G. Russel Breast cancer resistance protein (Bcrp1/Abcg2) limits net intestinal uptake of quercetin in rats by facilitating apical efflux of glucuronides Mol. Pharmacol. 67 2005 1999 2006
101. G. Williamson, I. Aeberli, L. Miguet, Z. Zhang, M.B. Sanchez, V. Crespy, D. Barron, P. Needs, P.A. Kroon, H. Glavinas, P. Krajcsi, and M. Grigorov Interaction of positional isomers of quercetin glucuronides with the transporter ABCC2 (cMOAT, MRP2) Drug Metab. Dispos. 35 2007 1262 1268
102. C.C. Wong, Y. Akiyama, T. Abe, J.D. Lippiat, C. Orfila, and G. Williamson Carrier-mediated transport of quercetin conjugates: involvement of organic anion transporters and organic anion transporting polypeptides Biochem. Pharmacol. 84 2012 564 570
103. K.A. O'Leary, A.J. Day, P.W. Needs, F.A. Mellon, N.M. O'Brien, and G. Williamson Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human beta glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism Biochem. Pharmacol. 65 2003 479 491
104. 14)C]quercetin-4′-glucoside in rats J. Agric. Food Chem. 56 2008 12127 12137
105. W. Mullen, C.A. Edwards, and A. Crozier Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions Br. J. Nutr. 96 2006 107 116
106. M. Gross, M. Pfeiffer, M. Martini, D. Campbell, J. Slavin, and J. Potter The quantitation of metabolites of quercetin flavonols in human urine Cancer Epidemiol. Biomark. Prev. 5 1996 711 720
107. J. Bieger, R. Cermak, R. Blank, V.C. de Boer, P.C. Hollman, J. Kamphues, and S. Wolffram Tissue distribution of quercetin in pigs after long-term dietary supplementation J. Nutr. 138 2008 1417 1420
108. D.R. Ferry, A. Smith, J. Malkhandi, D.W. Fyfe, P.G. de Takats, D. Anderson, J. Baker, and D.J. Kerr Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition Clin. Cancer Res. 4 1996 659 668
109. M. Zahedi, R. Ghiasvand, A. Feizi, G. Asgari, and L. Darvish Does quercetin improve cardiovascular risk factors and inflammatory biomarkers in women with type 2 diabetes: a double-blind randomized controlled clinical trial Int. J. Prev. Med. 4 2013 777 785
110. J.I. Dower, J.M. Geleijnse, L. Gijsbers, P.L. Zock, D. Kromhout, and P.C. Hollman Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health: a randomized, double-blind, placebo-controlled, crossover trial Am. J. Clin. Nutr. 101 2015 914 921
111. J.I. Dower, J.M. Geleijnse, L. Gijsbers, C. Schalkwijk, D. Kromhout, and P.C. Hollman Supplementation of the pure flavonoids epicatechin and quercetin affects some biomarkers of endothelial dysfunction and inflammation in (pre)hypertensive adults: a randomized double-blind, placebo-controlled, crossover trial J. Nutr. 145 2015 1459 1463
112. M. Amirchaghmaghi, Z. Delavarian, M. Iranshahi, M.T. Shakeri, P. Mosannen Mozafari, A.H. Mohammadpour, F. Farazi, and M.A. Iranshahy Randomized placebo-controlled double blind clinical trial of quercetin for treatment of oral Lichen planus J. Dent. Res. Dent. Clin. Dent. Prospects 9 2015 23 28
113. L. Packer, and J.R. Smith Extension of the lifespan of cultured normal human diploid cells by vitamin E Proc. Natl. Acad. Sci. U. S. A. 71 1974 4763 4767
114. S.I. Rattan, and B.F. Clark Kinetin delays the onset of ageing characteristics in human fibroblasts Biochem. Biophys. Res. Commun. 201 1994 665 672
115. G.A. McFarland, and R. Holliday Retardation of the senescence of cultured human diploidfibroblasts by carnosine Exp. Cell Res. 212 1994 167 175
116. L. Svendsen, S.I. Rattan, and B.F. Clark Testing garlic for possible anti-ageing effects on long-term growth characteristics, morphology and macromolecular synthesis of humanfibroblasts in culture J. Ethnopharmacol. 43 1994 125 133
117. I.P. Trougakos, N. Chondrogianni, A. Pimenidou, M. Katsiki, C. Tzavelas, and E.S. Gonos Slowing down cellular ageing in vitro S.I. Rattan, Modulating Ageing and Longevity 2003 Kluwer Academic Publishers Dordrecht 65 83
118. N. Chondrogianni, S. Kapeta, I. Chinou, K. Vassilatou, I. Papassideri, and E.S. Gonos Anti-ageing and rejuvenating effects of quercetin Exp. Gerontol. 45 2010 763 771
119. Y. Zhu, T. Tchkonia, T. Pirtskhalava, A.C. Gower, H. Ding, N. Giorgadze, A.K. Palmer, Y. Ikeno, G.B. Hubbard, M. Lenburg, S.P. O'Hara, N.F. LaRusso, J.D. Miller, C.M. Roos, G.C. Verzosa, N.K. LeBrasseur, J.D. Wren, J.N. Farr, S. Khosla, M.B. Stout, S.J. McGowan, H. Fuhrmann-Stroissnigg, A.U. Gurkar, J. Zhao, D. Colangelo, A. Dorronsoro, Y.Y. Ling, A.S. Barghouthy, D.C. Navarro, T. Sano, P.D. Robbins, L.J. Niedernhofer, and J.L. Kirkland The Achilles' heel of senescent cells: from transcriptome to senolytic drugs Aging Cell 2015 1 15
120. J.L. Kirkland Inflammation and cellular senescence: potential contribution to chronic diseases and disabilities with aging Public Policy Aging Rep. 23 2013 12 15
121. J.L. Kirkland, and T. Tchkonia Clinical strategies and animal models for developing senolytic agents Exp. Gerontol. S0531-5565 2014 291 295
122. Y.B. Shaik, M.L. Castellani, A. Perrella, F. Conti, V. Salini, S. Tete, B. Madhappan, J. Vecchiet, M.A. De Lutiis, A. Caraffa, and G. Cerulli Role of quercetin (a natural herbal compound) in allergy and inflammation J. Biol. Regul. Homeost. Agents 20 2006 47 52
123. S. Chirumbolo Quercetin as a potential anti-allergic drug: which perspectives? Iran. J. Allergy Asthma Immunol. 10 2011 139 140
124. D.A. Pashevin, L.V. Tumanovska, V.E. Dosenko, V.S. Nagibin, V.L. Gurianova, and A.A. Moibenko Antiatherogenic effect of quercetin is mediated by proteasome inhibition in the aorta and circulating leukocytes Pharmacol. Rep. 63 2011 1009 1018
125. F. Perez-Vizcaino, and J. Duarte Flavonols and cardiovascular disease Mol. Asp. Med. 31 2010 478 494
126. A.J. Larson, J.D. Symons, and T. Jalili Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms Adv. Nutr. 3 2012 39 46
127. F. Yang, L. Song, H. Wang, J. Wang, Z. Xu, and N. Xing Combination of quercetin and 2-methoxyestradiol enhances inhibition of human prostate cancer lncap and PC-3 cells xenograft tumor growth PLoS One 26 2015
128. C.H. Hung, S.H. Chan, P.M. Chu, and K.L. Tsai Quercetin is a potent anti-atherosclerotic compound by activation of SIRT1 signaling under oxLDL stimulation Mol. Nutr. Food Res. 2015 (Jul 23 [Epub ahead of print])
129. S. Chirumbolo Quercetin in cancer prevention and therapy Integr. Cancer Ther. 12 2013 97 102
130. S. Gorlach, J. Fichna, and U. Lewandowska Polyphenols as mitochondria-targeted anticancer drugs Cancer Lett. 366 2015 141 149
131. F. Dajas Life or death: neuroprotective and anticancer effects of quercetin J. Ethnopharmacol. 143 2012 383 396
132. G.L. Russo, M. Russo, C. Spagnuolo, I. Tedesco, S. Bilotto, R. Iannitti, and R. Palumbo Quercetin: a pleiotropic kinase inhibitor against cancer Cancer Treat. Res. 159 2014 185 205
133. A. Bruning Inhibition of mTOR signaling by quercetin in cancer treatment and prevention Anti Cancer Agents Med. Chem. 13 2013 1025 1031
134. A.K. Maurya, and M. Vinayak Modulation of PKC signaling and induction of apoptosis through suppression of reactive oxygen species and tumor necrosis factor receptor 1 (TNFR1): key role of quercetin in cancer prevention Tumour Biol. 2015 (Jun 16 [Epub ahead of print])
135. K. Sak Site-specific anticancer effects of dietary flavonoid quercetin Nutr. Cancer 66 2014 177 193
136. H.P. Kim, I. Mani, and V.A. Ziboh Effects of naturally-occurring flavonoids and bioflavonoids on epidermal cyclooxygenase from guinea pigs Prostaglandins Leukot. Essent. Fat. Acids 58 1998 17 24
137. K.M. Lee, M.K. Hwang, D.E. Lee, K.W. Lee, and H.J. Lee Protective effect of quercetin against arsenite-induced COX-2 expression by targeting PI3K in rat liver epithelial cells J. Agric. Food Chem. 58 2010 5815 5820
138. J.S. Yoon, M.K. Chae, S.Y. Lee, and E.J. Lee Anti-inflammatory effect of quercetin in a whole orbital tissue culture of Graves' orbitopathy Br. J. Ophthalmol. 96 2012 1117 1121
139. C. Angeloni, and S. Hrelia Quercetin reduces inflammatory responses in LPS-stimulated cardiomyoblasts Oxidative Med. Cell. Longev. 2012 2012 837104
140. S. Chirumbolo The role of quercetin, flavonols and flavones in modulating inflammatory cell function Inflamm. Allergy Drug Targets 9 2010 263 285
141. J. Ahn, H. Lee, S. Kim, J. Park, and T. Ha The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways Biochem. Biophys. Res. Commun. 373 2008 545 549
142. C.H. Jung, I. Cho, J. Ahn, T.I. Jeon, and T.Y. Ha Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes Phytother. Res. 27 2013 139 143
143. N. Siriwardhana, N.S. Kalupahana, M. Cekanova, M. LeMieux, B. Greer, and N. Moustaid Moussa Modulation of adipose tissue inflammation by bioactive food compounds J. Nutr. Biochem. 24 2013 613 623
144. M. Kobori Dietary quercetin and other polyphenols: attenuation of obesity R.R. Watson, V.R. Preedy, S. Zibadi, Polyphenols in Human Health and Disease 2014 Elsevier Science B. V Amsterdam 163 175
145. S.C. Bae, W.J. Jung, E.J. Lee, R. Yu, and M.K. Sung Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients J. Am. Coll. Nutr. 28 2009 56 62
146. H. Matsuno, H. Nakamura, K. Katayama, S. Hayashi, S. Kano, K. Yudoh, and Y. Kiso Effects of an oral administration of glucosamine-chondroitin-quercetin glucoside on the synovial fluid properties in patients with osteoarthritis and rheumatoid arthritis Biosci. Biotechnol. Biochem. 73 2009 288 292
147. P. Knekt, J. Kumpulainen, R. Järvinen, H. Rissanen, M. Heliövaara, A. Reunanen, T. Hakulinen, and A. Aromaa Flavonoid intake and risk of chronic diseases Am. J. Clin. Nutr. 76 2002 560 568
148. T. Hirano, M. Kawai, J. Arimitsu, M. Ogawa, Y. Kuwahara, K. Hagihara, Y. Shima, M. Narazaki, A. Ogata, M. Koyanagi, T. Kai, R. Shimizu, M. Moriwaki, Y. Suzuki, S. Ogino, I. Kawase, and T. Tanaka Preventative effect of a flavonoid, enzymatically modified isoquercitrin on ocular symptoms of Japanese cedar pollinosis Allergol. Int. 58 2009 373 382
149. M. Kawai, T. Hirano, J. Arimitsu, S. Higa, Y. Kuwahara, K. Hagihara, Y. Shima, M. Narazaki, A. Ogata, M. Koyanagi, T. Kai, R. Shimizu, M. Moriwaki, Y. Suzuki, S. Ogino, I. Kawase, and T. Tanaka Effect of enzymatically modified isoquercitrin, a flavonoid, on symptoms of Japanese cedar pollinosis: a randomized double-blind placebo controlled trial Int. Arch. Allergy Immunol. 149 2009 359 368
150. S.M. Jeong, M.J. Kang, H.N. Choi, J.H. Kim, and J.I. Kim Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice Nutr. Res. Pract. 6 2012 201 207
151. P.B. Lai, L. Zhang, and L.Y. Yang Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats Ren. Fail. 34 2012 83 87
152. P.S. Chaudry, J. Cabera, H.R. Juliani, and S.D. Varma Inhibition of human lens aldose reductase by flavonoids, sulindac, and indomethacin Biochem. Pharmacol. 32 1983 1995 1998
153. S.D. Varma, I. Mikuni, and J.H. Kinoshita Flavonoids as inhibitors of lens aldose reductase Science 188 1975 1215 1216
154. S.D. Varma, A. Mizuno, and J.H. Kinoshita Diabetic cataracts and flavonoids Science 195 1977 205 206
155. P. Valensia, C.L. Devehath, J.L. Richards, C. Farez, T. Khodabandehlou, R.A. Rosenbloom, and C. LeFante A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy: a preliminary report J. Diabetes Complicat. 19 2005 247 253
156. H.M. Eid, A. Nachar, F. Thong, G. Sweeney, and P.S. Haddad The molecular basis of the antidiabetic action of quercetin in cultured skeletal muscle cells and hepatocytes Pharmacogn. Mag. 11 2015 74 81
157. J. Kressler, M. Millard-Stafford, and G.L. Warren Quercetin and endurance exercise capacity: a systematic review and meta-analysis Med. Sci. Sports Exerc. 43 2011 2396 2404
158. C. Alarcón de la Lastra, M.J. Martín, and V. Motilva Antiulcer and gastroprotective effects of quercetin: a gross and histologic study Pharmacology 48 1994 56 62
159. T. Mizui, H. Sato, F. Hirose, and M. Doteuchi Effect of antiperoxidative drugs on gastric damage induced by ethanol in rats Life Sci. 41 1987 755 763
160. C.V. Rao, and M. Vijayakumar Effect of quercetin, flavonoids and alpha-tocopherol, an antioxidant vitamin, on experimental reflux oesophagitis in rats Eur. J. Pharmacol. 589 2008 233 238
161. P. Wu, L. Zhou, Y.J. Li, B. Luo, L.S. Yi, S.F. Chen, H.H. Sun, Y. Chen, Z.J. Cao, and S.C. Xu Protective effects of quercetin against chronic mixed reflux esophagitis in rats by inhibiting the nuclear factor-κB p65 and interleukin-8 signaling pathways J. Dig. Dis. 16 2015 319 326
162. J.E. Shin, J.M. Kim, E.A. Bae, Y.J. Hyun, and D.H. Kim In vitro inhibitory effect of flavonoids on growth, infection and vacuolation of Helicobacter pylori Planta Med. 71 2005 197 201
163. R. González-Segovia, J.L. Quintanar, E. Salinas, R. Ceballos-Salazar, F. Aviles-Jiménez, and J. Torres-López Effect of the flavonoid quercetin on inflammation and lipid peroxidation induced by Helicobacter pylori n gastric mucosa of guinea pig J. Gastroenterol. 43 2008 441 447
164. A.A. Hamdy, and M.A. Ibrahem Management of aphthous ulceration with topical quercetin: a randomized clinical trial J. Contemp. Dent. Pract. 11 2010 E009 E016
165. X.T. Hu, C. Ding, N. Zhou, and C. Xu Quercetin protects gastric epithelial cell from oxidative damage in vitro and in vivo Eur. J. Pharmacol. 754 2015 115 124
166. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics, 2014 CA Cancer J. Clin. 64 2014 9 29
167. M.R. Noori-Daloii, M. Momeny, M. Yousefi, F.G. Shirazi, M. Yaseri, N. Motamed, N. Kazemialiakbar, and S. Hashemi Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy Med. Oncol. 28 2011 1395 1404
168. R. Aalinkeel, B. Bindukumar, J.L. Reynolds, D.E. Sykes, S.D. Mahajan, K.C. Chadha, and S.A. Schwartz The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90 Prostate 2008 1773-1789 68
169. C.Y. Young, Y. Tian, Z. Liu, M. Zhang, and H. Lou Suppression of the androgen receptor function by quercetin through protein-protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells Mol. Cell. Biochem. 339 2010 253 262
170. F. Yang, L. Song, H. Wang, J. Wang, Z. Xu, and N. Xing Combination of quercetin and 2-methoxyestradiol enhances inhibition of human prostate cancer LNCaP and PC-3 cells xenograft tumor growth PLoS One 10 2015
171. F. Yang, L. Song, H. Wang, J. Wang, Z. Xu, and N. Xing Quercetin in prostate cancer: chemotherapeutic and chemopreventive effects, mechanisms and clinical application potential (review) Oncol. Rep. 33 2015 2659 2668
172. T.N. Kaul, E. Middleton Jr., and P.L. Ogra Antiviral effect of flavonoids on human viruses J. Med. Virol. 15 1985 71 79
173. O. Gonzalez, V. Fontanes, S. Raychaudhuri, R. Loo, J. Loo, V. Arumugaswami, R. Sun, A. Dasgupta, and S.W. French The heat shock protein inhibitor quercetin attenuates hepatitis C virus production Hepatology 2009 1756-1764 50
174. D.C. Nieman, D.A. Henson, S.J. Gross, D.P. Jenkins, J.M. Davis, E.A. Murphy, M.D. Carmichael, C.L. Dumke, A.C. Utter, S.R. McAnulty, L.S. McAnulty, and E.P. Mayer Quercetin reduces illness but not immune perturbations after intensive exercise Med. Sci. Sports Exerc. 39 2007 1561 1569
175. D. Henson, D. Nieman, J.M. Davis, C. Dumke, S. Gross, A. Murphy, M. Carmichael, D.P. Jenkins, J. Quindry, S. McAnulty, L. McAnulty, A. Utter, and E. Mayer Post-160-km race illness rates and decreases in granulocyte respiratory burst and salivary IgA output are not countered by quercetin ingestion Int. J. Sports Med. 29 2008 856 863
176. J.W. Betts, A.S. Sharili, L.M. Phee, and D.W. Wareham In vitro activity of epigallocatechin gallate and quercetin alone and in combination versus clinical isolates of methicillin-resistant Staphylococcus aureus J. Nat. Prod. 2015 (Aug 12 [Epub ahead of print])
177. M. Anjaneyulu, K. Chopra, and I. Kaur Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice J. Med. Food 6 2003 391 395
178. P. Bhutada, Y. Mundhada, K. Bansod, A. Ubgade, M. Quazi, S. Umathe, and D. Mundhada Reversal by quercetin of corticotrophin releasing factor induced anxiety- and depression-like effect in mice Prog. Neuro-Psychopharmacol. Biol. Psychiatry 34 2010 955 960
179. A. Priprem, J. Watanatorn, S. Sutthiparinyanont, W. Phachonpai, and S. Muchimapura Anxiety and cognitive effects of quercetin liposomes in rats Nanomedicine 4 2008 70 78
180. S.O. Adewole, E.A. Caxton-Martins, and J.A. Ojewole Protective effect of quercetin on the morphology of pancreatic beta-cells of streptozotocintreated diabetic rats Afr. J. Tradit. Complement. Altern. Med. 4 2006 64 74
181. I. Holzmann, L.M. da Silva, J.A. Corrêa da Silva, V.M. Steimbach, and M.M. de Souza Antidepressant-like effect of quercetin in bulbectomized mice and involvement of the antioxidant defenses, and the glutamatergic and oxidonitrergic pathways Pharmacol. Biochem. Behav. 136 2015 55 63
182. D. Joshi, P.S. Naidu, A. Singh, and S.K. Kulkarni Protective effect of quercetin on alcohol abstinence-induced anxiety and convulsions J. Med. Food 8 2005 392 396
183. S.E. Dixon Clarke, and R.R. Ramsay Dietary inhibitors of monoamine oxidase A J. Neural Transm. 118 2011 1031 1041
184. K. Kawabata, Y. Kawai, and J. Terao Suppressive effect of quercetin on acute stress-induced hypothalamic-pituitary adrenal axis response in Wistar rats J. Nutr. Biochem. 21 2010 374 380
185. K. Chander, K. Vaibhav, M. Ejaz Ahmed, H. Javed, R. Tabassum, A. Khan, M. Kumar, A. Katyal, F. Islam, and M.S. Siddiqui Quercetin mitigates lead acetate-induced behavioral and histological alterations via suppression of oxidative stress, Hsp-70, Bak and upregulation of Bcl-2 Food Chem. Toxicol. 68 2014 297 306
186. +-ATPase activities Physiol. Behav. 135 2014 152 167.7
187. D. Pal, and A.K. Mitra MDR- and CYP3A4-mediated drug-herbal interactions Life Sci. 78 2006 2131 2145
188. J.S. Choi, Y.J. Piao, and K.W. Kang Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin Arch. Pharm. Res. 34 2011 607 613
189. Y. Chen, P. Xiao, D.S. Ou-Yang, L. Fan, D. Guo, Y.N. Wang, Y. Han, J.H. Tu, G. Zhou, Y.F. Huang, and H.H. Zhou Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers Clin. Exp. Pharmacol. Physiol. 36 2009 828 833
190. K.A. Kim, P.W. Park, and J.Y. Park Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers Eur. J. Clin. Pharmacol. 65 2009 609 614
191. Y.H. Wang, P.D. Chao, S.L. Hsiu, K.C. Wen, and Y.C. Hou Lethal quercetin-digoxin interaction in pigs Life Sci. 74 2004 1191 1197
192. E. Chan, A. Hegde, and X. Chen Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats J. Pharm. Pharmacol. 61 2009 451 458
193. A. Kale, S. Gawande, S. Kotwal, S. Netke, W. Roomi, V. Ivanov, A. Niedzwiecki, and M. Rath Studies on the effects of oral administration of nutrient mixture, quercetin and red onions on the bioavailability of epigallocatechin gallate from green tea extract Phytother. Res. 24 2010 S48 S55
194. Y.J. Moon, and M.E. Morris Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats Mol. Pharm. 4 2007 865 872
195. P.S. Naidu, A. Singh, D. Joshi, and S.K. Kulkarni Possible mechanisms of action in quercetin reversal of morphine tolerance and dependence Addict. Biol. 8 2003 327 336
196. C. Chen, J. Zhou, and C. Ji Quercetin: a potential drug to reverse multidrug resistance Life Sci. 87 2010 333 338
197. K. Morino, N. Matsukara, T. Kawachi, H. Ohgaki, T. Sugimura, and I. Hirono Carcinogenicity test of quercetin and rutin in golden hamsters by oral administration Carcinogenesis 3 1982 93 97
198. R. Pérez-Pastén, E. Martínez-Galero, and G. Chamorro-Cevallos Quercetin and naringenin reduce abnormal development of mouse embryos produced by hydroxyurea J. Pharm. Pharmacol. 62 2010 1003 1009
199. K. Vanhees, L. de Bock, R.W. Godschalk, F.J. van Schooten, and S.B. van Waalwijk van Doorn-Khosrovani Prenatal exposure to flavonoids: implication for cancer risk Toxicol. Sci. 120 2011 59 67
200. G. Cantero, C. Campanella, S. Mateos, and F. Corte's Topoisomerase II inhibition and high yield of endoreduplication induced by the flavonoids luteolin and quercetin Mutagenesis 21 2006 321 325
201. S. Sudan, and H.P. Rupasinghe Quercetin-3-O-glucoside induces human DNA topoisomerase II inhibition, cell cycle arrest and apoptosis in hepatocellular carcinoma cells Anticancer Res. 34 2014 1691 1699
202. S. Sudan, and H.V. Rupasinghe Antiproliferative activity of long chain acylated esters of quercetin-3-O-glucoside in hepatocellular carcinoma HepG2 cells Exp. Biol. Med. (Maywood) 2015 (Feb 13 [Epub ahead of print])
203. A.M. Hossion, Y. Zamami, R.K. Kandahary, T. Tsuchiya, W. Ogawa, A. Iwado, and K. Sasaki Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents J. Med. Chem. 54 2011 3686 3703
204. S.L. Miles, M. McFarland, and R.M. Niles Molecular and physiological actions of quercetin: need for clinical trials to assess its benefits in human disease Nutr. Rev. 72 2014 720 734
205. Phenol-Explorer, Database on polyphenol content in food, Food composition; http://phenol-explorer.eu/contents/polyphenol/330 (Accessed September 16, 2015).
206. U.S. National Library of Medicine, Open Chemistry Database, http://pubchem.ncbi.nlm.nih.gov/compound/5280343#section=Top (Accessed September 16, 2015).
207. USDA Database for the Flavonoid Content of Selected Foods, Release 3.1, December 2013, Slightly revised, May 2014, prepared by Bhagwat, S.; Haytowitz, D.B.; Holden, J.M. (ret.), http://www.ars.usda.gov/News/docs.htm?docid=6231 (Accessed September 16, 2015).
208. Medscape, Drug & Disease, Quercetin (Herbs/Suppl.), http://reference.medscape.com/drug/quercetin-344495#3 (Accessed September 16, 2015).
209. Medscape, Drug & Disease, Quercetin (Herbs/Suppl.), http://reference.medscape.com/drug/quercetin-344495#2 (Accessed September 16, 2015).